St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Mary V. Relling, PharmD
Emeritus, St. Jude Faculty
On this page:
Contact Information
Mary V. Relling, PharmD
Pharmacy and Pharmaceutical Sciences
MS 313, Room I5112
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Education
BS – University of Arizona PharmD – University of Utah College of Pharmacy
Honors & Awards
- 2020 ASCPT/FDA Dr. William B. Abrams Lectureship Award
- 2014 Rigshospitalet's International KFJ Award
- 2013 American Society for Clinical Pharmacology and Therapeutics, Rawls-Palmer Progress in Medicine Award
- 2012 Mentor of the Year, St. Jude Postdoctoral Association,
- 2009 Institute of Medicine
- 2009 Team Science Award, American Association for Cancer Research
- 2009 Pediatric Oncology Award and Lecture Recipient, American Society of Clinical Oncology
- 2007 Alumni Association Professional Achievement Award, University of Arizona
- 2002 Gerhard Levy Distinguished Lecture Award, SUNY, Buffalo
- 1998 Leon I. Goldberg Young Investigator Award, American Society for Clinical Pharmacology and Therapeutics
Research Interests
- Clinical implementation of pharmacogenomic testing
- Host- and treatment-related risk factors affecting antileukemic therapy
- Improving the drug therapy of childhood leukemia
Clinical Trials
Recruiting
Study goal:
1) Test each patient for hundreds of gene variations that might be important for drug use. All of the gene test results will be in the research laboratory, but as time goes on, the study will evaluate scientific evidence and selectively move test results for a few genes into the medical record if the evidence strongly shows that the result can help in better prescribing of drugs for patients; 2) Estimate how often pharmacogenetic test results are moved from research tests into a patient’s medical record; 3) Use methods to choose which of these tests should be put in the medical record; 4) Use computer-based tools in the electronic medical record to help doctors use gene test results when prescribing drugs; 5) Share feelings and concerns of patients and their families about gene test information being put in their medical record.
